University of Leicester
Browse

Specific Gait Changes in Prodromal Hereditary Spastic Paraplegia Type 4: preSPG4 Study

Download (1.12 MB)
journal contribution
posted on 2023-02-17, 11:20 authored by C Laßmann, W Ilg, M Schneider, M Völker, DFB Haeufle, R Schüle, M Giese, M Synofzik, L Schöls, TW Rattay

Background: In hereditary spastic paraplegia type 4 (SPG4), subclinical gait changes might occur years before patients realize gait disturbances. The prodromal phase of neurodegenerative disease is of particular interest to halt disease progression by future interventions before impairment has manifested. Objective: The objective of this study was to identify specific movement abnormalities before the manifestation of gait impairment and quantify disease progression in the prodromal phase. 

Methods: Seventy subjects participated in gait assessment, including 30 prodromal SPAST pathogenic variant carriers, 17 patients with mild-to-moderate manifest SPG4, and 23 healthy control subjects. An infrared-camera-based motion capture system assessed gait to analyze features such as range of motion and continuous angle trajectories. Those features were correlated with disease severity as assessed by the Spastic Paraplegia Rating Scale, neurofilament light chain as a fluid biomarker indicating neurodegeneration, and motor-evoked potentials. 

Results: Compared with healthy control subjects, we found an altered gait pattern in prodromal pathogenic variant carriers during the swing phase in the segmental angle of the foot (Dunn's post hoc test, q = 3.1) and heel ground clearance (q = 2.8). Furthermore, range of motion of segmental angle was reduced for the foot (q = 3.3). These changes occurred in prodromal pathogenic variant carriers without quantified leg spasticity in clinical examination. Gait features correlated with neurofilament light chain levels, central motor conduction times of motor-evoked potentials, and Spastic Paraplegia Rating Scale score. 

Conclusions: Gait analysis can quantify changes in prodromal and mild-to-moderate manifest SPG4 patients. Thus, gait features constitute promising motor biomarkers characterizing the subclinical progression of spastic gait and might help to evaluate interventions in early disease stages. 

Funding

This work was supported by the Forum Ge(h)nmit HSP and the Förderverein für HSP-Forschung e.V. (grant to L.S. andT.W.R.). T.W.R. received funding from the University of Tübingen, medi-cal faculty, for the Clinician Scientist Program Grant: #386–0-0. L.S. andR.S are members of the European Reference Network for Rare Neurologi-cal Diseases, Project ID 739510. The Study was supported by theBundesministerium für Forschung und Bildung (BMBF) through fund forthe TreatHSP network (01GM1905 to R.S.).

History

Citation

Laßmann, C., Ilg, W., Schneider, M., Völker, M., Haeufle, D.F.B., Schüle, R., Giese, M., Synofzik, M., Schöls, L. and Rattay, T.W. (2022), Specific Gait Changes in Prodromal Hereditary Spastic Paraplegia Type 4: preSPG4 Study. Mov Disord, 37: 2417-2426. https://doi.org/10.1002/mds.29199

Author affiliation

Department of Genetics and Genome Biology

Version

  • VoR (Version of Record)

Published in

Movement Disorders

Volume

37

Issue

12

Pagination

2327-2468

Publisher

Wiley

issn

0885-3185

eissn

1531-8257

Acceptance date

2022-08-02

Copyright date

2022

Available date

2023-02-17

Language

eng

Usage metrics

    University of Leicester Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC